Low Cap Bios. IMO3 Sep 2019 12:14
Large Pharmas don't seem to have a great Interest In low MC Bios. ANY buyouts of minnows. That are Not In some way part of a larger Pharma. With no Interest In SCIB1 In all that time, A compound that seems to have a fair measure of success. Only starting the next Trial, SCIB1 now seemingly having to be Included with another drug to get better results to gain Interest . IMO a long road to Go. Unless In the possibility of a Very quick excellent trial result and Partner/Buyout AIMOO